SETD2 and colorectal carcinoma: Previous studies have demonstrated that serine and arginine-rich splicing factor 6 regulates AS to mediate CRC progression (Wan et al., 2019), and SET domain containing 2, histone lysine methyltransferase (SETD2) modulated AS events during intestinal tumorigenesis (Yuan et al., 2017).